Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

12.02.2024

1 BMC Cancer
1 Br J Cancer
1 Cancer
3 Gynecol Oncol
2 Histopathology
4 Int J Gynecol Pathol
1 J Clin Oncol
1 Oncology



    BMC Cancer

  1. JAMALZADEH S, Dai J, Lavikka K, Li Y, et al
    Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma.
    BMC Cancer. 2024;24:173.
    >> Share


    Br J Cancer

  2. POSTEL-VINAY S, Coves J, Texier M, Aldea M, et al
    Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
    Br J Cancer. 2023 Dec 14. doi: 10.1038/s41416-023-02514.
    >> Share


    Cancer

  3. PARK S, Kim YJ, Min YJ, Mortimer PGS, et al
    Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
    Cancer. 2023 Oct 16. doi: 10.1002/cncr.35059.
    >> Share


    Gynecol Oncol

  4. POTHURI B, Han S, Chase DM, Heitz F, et al
    Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
    Gynecol Oncol. 2024;184:168-177.
    >> Share

  5. TELLES R, Zimmerman MB, Thaker PH, Slavich GM, et al
    Rural-urban disparities in psychosocial functioning in epithelial ovarian cancer patients.
    Gynecol Oncol. 2024;184:139-145.
    >> Share

  6. HARI A, Chang J, Villanueva C, Ziogas A, et al
    Short-term survival analysis of a risk-adjusted model for ovarian cancer care.
    Gynecol Oncol. 2024;184:123-131.
    >> Share


    Histopathology

  7. KOMMOSS FKF
    Lessons from genomic profiling: towards a molecular-based classification of ovarian Sertoli-Leydig cell tumour.
    Histopathology. 2024;84:712-714.
    >> Share

  8. KOMMOSS FKF, Chong AS, Apellaniz-Ruiz M, Turashvili G, et al
    Teratoma-associated and so-called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features.
    Histopathology. 2024;84:683-696.
    >> Share


    Int J Gynecol Pathol

  9. XU J, McGregor SM, Park KJ, Weisman PS, et al
    Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ss-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association
    Int J Gynecol Pathol. 2024;43:145-148.
    >> Share

  10. BHARDWAJ S, Banet N, Gaston EC
    Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl.
    Int J Gynecol Pathol. 2024;43:140-144.
    >> Share

  11. SMITHGALL MC, Yemelyanova A, Mathew S, Gogineni S, et al
    HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
    Int J Gynecol Pathol. 2024;43:134-139.
    >> Share

  12. KENDALL BARTU M, Nemejcova K, Michalkova R, Bui QH, et al
    Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
    Int J Gynecol Pathol. 2024;43:123-133.
    >> Share


    J Clin Oncol

  13. LORUSSO D, Raspagliesi F, Ronzulli D, Valabrega G, et al
    Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.
    J Clin Oncol. 2024 Feb 5:JCO2301225. doi: 10.1200/JCO.23.01225.
    >> Share


    Oncology

  14. MIYAGAWA Y, Kitazawa M, Tokumaru S, Nakamura S, et al
    Impact of Oophorectomy on Survival and Improving Nutritional Status in Ovarian Metastasis from Colorectal Adenocarcinoma.
    Oncology. 2024;102:114-121.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016